s In Amneal Pharmaceuticals LLC v. Almirall, LLC [2020-1106] (June 4, 2020), the Federal Circuit denied Almirall’s motion for attorneys fees and costs after Amneal dismissed its appeal from an adverse ruling in an IPR, including fees for conducting the … Continue reading IPR Attorneys’ Fees are not Awardable under Section 285